Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2000
08/30/2000CN1265102A Benzothia (oxa) diazol derivatives and their use as endothelin-receptor antagonists
08/30/2000CN1265096A Hydrazine derivatives
08/30/2000CN1055924C Novel aminoalkyl benzoxazolinones and benzothizolinones and pharmaceutical compsns. and method for preparing same
08/29/2000US6111084 Sialyl lewis mimetics produced by solid phase synthesis; antiinflammatory agents
08/29/2000US6111078 Staphylococcus aureus rsbU-1
08/29/2000US6111076 Human G-protein coupled receptor (HIBCD07)
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110960 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
08/29/2000US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents
08/29/2000US6110945 An antiinflammatory agent inhibiting the binding of integrins to their ligands; in the prophylaxis for treating immune or inflammatory disorders
08/29/2000US6110944 LTA4, hydrolase inhibitors
08/29/2000US6110941 Compounds analogous to thalidomide from the class comprising piperidine-2,6-diones
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor
08/29/2000US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
08/29/2000US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
08/29/2000US6110919 Diazabicyclic neurokinin antagonists
08/29/2000US6110910 Antiinflammatory agents, antiarthritic agents, antirheumatic agents, anticarcinogenic agents
08/29/2000US6110896 Peptidyl compounds and their therapeutic use
08/29/2000US6110460 Methods of using morphogen analogs
08/24/2000WO2000049144A2 Pyk2 binding proteins
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000049011A1 Prothease inhibitors
08/24/2000WO2000049005A1 Bicyclic compounds and their use as integrin receptor ligands
08/24/2000WO2000048996A2 β-ALANINE DERIVATIVES
08/24/2000WO2000048994A1 Thioamide derivatives
08/24/2000WO2000048992A1 Acylated aminoacetonitriles as cysteine protease inhibitors
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048988A1 Phenylalaninol derivatives
08/24/2000WO2000048643A1 Biodegradable, injectable oligomer-polymer composition
08/24/2000WO2000048639A1 Immobilized labeling compounds and methods
08/24/2000WO2000048610A1 Chemical compounds
08/24/2000WO2000048609A1 Chemical compounds
08/24/2000WO2000048603A1 DIBENZO-AZEPINE DERIVATIVES AS αV INTEGRIN RECEPTOR ANTAGONISTS
08/24/2000WO2000048597A1 Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
08/24/2000WO2000048595A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000WO2000048593A1 Epoxide hydrolase complexes and methods therewith
08/24/2000WO2000048591A1 Combinations for the treatment of diseases involving angiogenesis
08/24/2000WO2000048590A1 Substituted stilbene compounds with vascular damaging activity
08/24/2000WO2000048588A1 Pharmaceutical topical compositions containing a non-steroidal antiinflammatory drug
08/24/2000WO2000048587A1 Combinations of formoterol and fluticasone propionate for asthma
08/24/2000WO2000048581A2 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
08/24/2000WO2000048571A1 Spontaneously dispersible n-benzoyl staurosporine compositions
08/24/2000WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
08/24/2000WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA
08/24/2000WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000010611A3 Drug targeting
08/24/2000WO2000004917A9 USE OF HC gp-39 IN IMMUNE DISEASES
08/24/2000WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
08/24/2000DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha
08/24/2000DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs
08/24/2000CA2371824A1 .beta.-alanine derivatives
08/24/2000CA2368537A1 Combinations of formoterol and fluticasone propionate for asthma
08/24/2000CA2363670A1 Chemical compounds
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362862A1 Bicyclic compounds and their use as integrin receptor ligands
08/24/2000CA2362860A1 Immobilized labeling compounds and methods
08/24/2000CA2362538A1 Secreted proteins and polynucleotides encoding them
08/24/2000CA2362334A1 Dibenzo-azepine derivatives as .alpha.v integrin receptor antagonists
08/24/2000CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000CA2362306A1 Chemical compounds
08/24/2000CA2299117A1 Antimycotic compositions
08/23/2000EP1029865A2 Process and intermediates for preparing 5-lipoxygenase inhibitors
08/23/2000EP1028977A2 Bifidus stimulating peptides
08/23/2000EP1028974A1 Secreted proteins and polynucleotides encoding them
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028954A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/23/2000EP1028953A1 Aromatic heterocyclic compounds as anti-inflammatory agents
08/23/2000EP1028951A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
08/23/2000EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
08/23/2000EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028942A2 Dipeptide nitriles
08/23/2000EP1028739A2 Use of protein h as cytostatic agent
08/23/2000EP1028710A1 Topical compositions for nsai drug delivery
08/23/2000EP0844873A4 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
08/23/2000EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/23/2000EP0674642B1 Pyrazolopyrimidines as crf antagonists
08/23/2000CN1264382A Novel compounds
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1263777A Tibetan-medicinal bath for treating rheumatism and its preparing process
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055629C Making up method for medicinal liquid of ice guide therapeutic method on channels and acupuncture point
08/22/2000US6107482 Nitrogenous macrocyclic compounds
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107335 Esculentin A and esculentin B, a process for their preparation, and their use in the manufacture of medicaments
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107324 5-HT2A receptor inverse agonists
08/22/2000US6107315 Nervous system disorders
08/22/2000US6107311 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/22/2000US6107305 Antiproferative agent, antiinflammatory agents
08/22/2000US6107300 Arylamino fused pyrimidines
08/22/2000US6107297 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists
08/22/2000US6107294 Nervous system and psychological disorders
08/22/2000US6107293 Analgesics
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107284 Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments
08/22/2000US6107075 Human elastase IV
1 ... 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 ... 1272